UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 240

Sortiert nach

(−)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection

Neuropharmacology, 2003-12, Vol.45 (7), p.895-906

2003

Volltextzugriff (PDF)

Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function: I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain

Neuropharmacology, 2001, Vol.40 (1), p.1-9

2001

Volltextzugriff (PDF)

In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article

Amino acids, 2002-01, Vol.23 (1-3), p.207-211

2002

Volltextzugriff (PDF)

Image et droit: du ius imaginis au droit à l'image

2022

Volltextzugriff (PDF)

A Selective Metabotropic Glutamate Receptor 7 Agonist: Activation of Receptor Signaling via an Allosteric Site Modulates Stress Parameters In vivo

Proceedings of the National Academy of Sciences - PNAS, 2005-12, Vol.102 (51), p.18712-18717

2005

Volltextzugriff (PDF)

The Non-competitive Antagonists 2-Methyl-6-(phenylethynyl)pyridine and 7-Hydroxyiminocyclopropan[b]chromen-1a-carboxylic Acid Ethyl Ester Interact with Overlapping Binding Pockets in the Transmembrane Region of Group I Metabotropic Glutamate Receptors

The Journal of biological chemistry, 2000-10, Vol.275 (43), p.33750-33758

2000

Volltextzugriff (PDF)

CPCCOEt, a Noncompetitive Metabotropic Glutamate Receptor 1 Antagonist, Inhibits Receptor Signaling Without Affecting Glutamate Binding

Molecular pharmacology, 1999-03, Vol.55 (3), p.453

1999

Volltextzugriff (PDF)

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

Neuropharmacology, 1999-10, Vol.38 (10), p.1493-1503

1999

Volltextzugriff (PDF)

[ 3H]-M-MPEP, a Potent, Subtype-Selective Radioligand for the Metabotropic Glutamate Receptor Subtype 5

Bioorganic & medicinal chemistry letters, 2002-02, Vol.12 (3), p.407-409

2002

Volltextzugriff (PDF)

Chiral Resolution, Pharmacological Characterization, and Receptor Docking of the Noncompetitive mGlu1 Receptor Antagonist (±)-2-Hydroxyimino- 1a,2-dihydro-1H-7-oxacyclopropa[b]naphthalene-7a-carboxylic Acid Ethyl Ester

Journal of medicinal chemistry, 2000-11, Vol.43 (23), p.4428-4436

2000

Volltextzugriff (PDF)

(-)-PH Sr, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection

Neuropharmacology, 2003-12, Vol.45 (7), p.895-906

2003

Volltextzugriff (PDF)

Preterm Breast-Feeding Pays Off

MCN, the American journal of maternal child nursing, 1987-09, Vol.12 (5), p.308-308

1987

Volltextzugriff (PDF)

Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function

Neuropharmacology, 2001-01, Vol.40 (1), p.1-9

2001

Volltextzugriff (PDF)

Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain

Neuropharmacology, 2000-11, Vol.40 (1), p.1-9

2000

Volltextzugriff (PDF)

Discovery and characterization of non-competitive antagonists of group I metabotropic glutamate receptors

Farmaco (Società chimica italiana : 1989), 2001-01, Vol.56 (1), p.95-99

2001

Volltextzugriff (PDF)

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist: Metabotropic Glutamate Receptors

Neuropharmacology, 1999, Vol.38 (10), p.1493-1503

1999

Volltextzugriff (PDF)

Surgical experience in cancer of the cervix

American journal of obstetrics and gynecology, 1961-07, Vol.82 (1), p.64-73

1961

Volltextzugriff (PDF)

Sexual dimorphism in immunity across animals: a meta‐analysis

Ecology letters, 2018-12, Vol.21 (12), p.1885-1894

2018

Volltextzugriff (PDF)

Off-Label Use of Topical Minoxidil in Alopecia: A Review

American journal of clinical dermatology, 2019-04, Vol.20 (2), p.237-250

2019

Volltextzugriff (PDF)

Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation

Journal of molecular and cellular cardiology, 2014-09, Vol.74, p.151-161

2014

Volltextzugriff (PDF)

A Product Review of Alternative Oil-Based Intravenous Fat Emulsions

Nutrition in Clinical Practice, 2016-10, Vol.31 (5), p.610-618

2016

Volltextzugriff (PDF)

Permanent chemotherapy-induced alopecia: awareness and attitudes among health care providers

Supportive care in cancer, 2020-06, Vol.28 (6), p.2887-2890

2020

Volltextzugriff (PDF)

The influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification the IRIVASC-trial

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

DAF-16/FOXO requires Protein Phosphatase 4 to initiate transcription of stress resistance and longevity promoting genes

Nature communications, 2020-01, Vol.11 (1), p.138-138, Article 138

2020

Volltextzugriff (PDF)

Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD

Current Alzheimer research, 2010-06, Vol.7 (4), p.280

2010

Volltextzugriff (PDF)

1 – 25 von 240

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(198)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(210)
Japanisch
(35)
Französisch
(15)
Deutsch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

(−)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection

Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function: I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain

In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article

Image et droit: du ius imaginis au droit à l'image

A Selective Metabotropic Glutamate Receptor 7 Agonist: Activation of Receptor Signaling via an Allosteric Site Modulates Stress Parameters In vivo

The Non-competitive Antagonists 2-Methyl-6-(phenylethynyl)pyridine and 7-Hydroxyiminocyclopropan[b]chromen-1a-carboxylic Acid Ethyl Ester Interact with Overlapping Binding Pockets in the Transmembrane Region of Group I Metabotropic Glutamate Receptors

CPCCOEt, a Noncompetitive Metabotropic Glutamate Receptor 1 Antagonist, Inhibits Receptor Signaling Without Affecting Glutamate Binding

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

[ 3H]-M-MPEP, a Potent, Subtype-Selective Radioligand for the Metabotropic Glutamate Receptor Subtype 5

Chiral Resolution, Pharmacological Characterization, and Receptor Docking of the Noncompetitive mGlu1 Receptor Antagonist (±)-2-Hydroxyimino- 1a,2-dihydro-1H-7-oxacyclopropa[b]naphthalene-7a-carboxylic Acid Ethyl Ester

(-)-PH Sr, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection

Preterm Breast-Feeding Pays Off

Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function

Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain

Discovery and characterization of non-competitive antagonists of group I metabotropic glutamate receptors

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist: Metabotropic Glutamate Receptors

Surgical experience in cancer of the cervix

Sexual dimorphism in immunity across animals: a meta‐analysis

Off-Label Use of Topical Minoxidil in Alopecia: A Review

Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation

A Product Review of Alternative Oil-Based Intravenous Fat Emulsions

Permanent chemotherapy-induced alopecia: awareness and attitudes among health care providers

The influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification the IRIVASC-trial

DAF-16/FOXO requires Protein Phosphatase 4 to initiate transcription of stress resistance and longevity promoting genes

Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD

Suchergebnisse filtern